Skip to main content
    I

    INVO Fertility, Inc. (IVF)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $2.40
    -0.20 (-7.69%)

    Market Cap: $3.10M

    Last updated: Nov 17, 2026 at 11:00 AM ET

    INVO Fertility, Inc. (IVF) Financials: Revenue, Profit and Cash Flow

    Updated Aug 14, 2026. Financial statements from company filings, amounts in US dollars.

    INVO Fertility reported revenue of $6.84M for the fiscal year ended Dec 31, 2025, up 4.7% from the year before. That year, net income was -$23.32M with a net margin of -340.9%, operating cash flow was -$7.01M and free cash flow was -$7.06M. The quarter ended Jun 30, 2026 had revenue of $2.18M and net income of $888.74K.

    Revenue and Margins

    The operating margin was -85.4% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $50.90K, a compound annual rate of 72.4%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$6.84M+4.7%37.0%-85.4%-340.9%
    Dec 2024$6.53M+116.3%44.0%-124.4%-139.3%
    Dec 2023$3.02M+267.4%36.0%-224.0%-266.0%
    Dec 2022$822.20K-80.2%-3.5%-1292.5%-1324.8%
    Dec 2021$4.16M+301.1%96.5%-125.4%-160.0%
    Dec 2020$1.04M-29.9%91.4%-531.7%-804.7%
    Dec 2019$1.48M+199.4%90.6%-120.8%-146.4%
    Dec 2018$494.38K+75.2%81.7%-532.8%-622.2%
    Dec 2017$282.14K+454.3%81.6%-227.0%-248.9%
    Dec 2016$50.90KN/A70.3%-4146.1%-4173.3%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Jun 2026, net income turned positive after a loss in the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$6.84M$6.53M$3.02M$822.20K$4.16M$1.04M$1.48M$494.38K$282.14K$50.90K
    Cost of revenue$4.31M$3.66M$1.93M$850.77K$145.05K$88.76K$139.67K$90.37K$51.95K$15.09K
    Gross profit$2.53M$2.87M$1.09M-$28.57K$4.02M$948.53K$1.34M$404.01K$230.19K$35.81K
    Research and development$0$489.66K$165.94K$544.04K$216.43K$398.43K$0$0$0$0
    Operating income-$5.84M-$8.13M-$6.77M-$10.63M-$5.22M-$5.51M-$1.79M-$2.63M-$640.42K-$2.11M
    Net income-$23.32M-$9.10M-$8.03M-$10.89M-$6.65M-$8.35M-$2.17M-$3.08M-$702.16K-$2.12M
    EBITDA-$3.51M-$7.14MN/AN/AN/A-$5.48M-$1.76M-$2.63MN/A-$2.11M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Revenue$2.18M$2.02M$1.58M$1.76M$1.86M$1.64M$1.69M$1.43M$1.84M$1.58M$1.38M$974.89K
    Gross profit$617.10K$727.83K$536.86K$629.35K$770.05K$592.26K$728.55K$444.69K$974.95K$726.05K$495.00K$393.93K
    Operating income-$1.29M-$1.59M-$1.41M-$1.64M-$1.59M-$2.46M-$3.98M-$1.30M-$1.90M-$946.37K-$1.51M-$886.29K
    Net income$888.74K-$5.54M$2.01M-$2.64M-$5.28M-$17.40M-$3.62M-$1.63M-$2.25M-$1.60M-$1.99M-$1.25M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $2.23M exceeded cash and equivalents by $150.53K.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$20.22M$46.45M$18.51M$3.71M$10.47M$10.95M$1.80M$777.35K$266.41K$286.23K
    Current assets$2.76M$1.32M$1.26M$621.09K$6.31M$10.54M$1.54M$731.11K$234.38K$251.39K
    Cash and equivalents$2.08M$741.40K$232.42K$90.14K$5.68M$10.10M$1.24M$212.24K$25.76K$152.40K
    Total liabilities$13.00M$33.70M$17.61M$4.69M$3.16M$5.20M$5.51M$3.50M$5.26M$4.90M
    Short-term debt$1.48M$6.58M$1.69M$922.83K$221.99K$716.39K$21.36K$395.59K$210.89K$220.89K
    Long-term debt$744.73K$1.13M$1.25MN/AN/AN/AN/AN/AN/AN/A
    Shareholder equity$7.22M$12.75M$892.83K-$977.61K$7.31M$5.74M-$3.71M-$2.72M-$4.99M-$4.62M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total assets$25.83M$24.66M$20.22M$18.83M$19.32M$31.74M$46.45M$17.02M$18.03M$18.32M$18.51M$19.48M
    Total liabilities$9.34M$9.63M$13.00M$12.98M$16.69M$28.41M$33.70M$17.04M$16.67M$18.31M$17.61M$19.10M
    Cash and equivalents$3.73M$4.90M$2.08M$355.89K$549.18K$840.41K$741.40K$471.59K$942.93K$475.13K$232.42K$1.06M
    Shareholder equity$16.49M$15.02M$7.22M$5.85M$2.63M$3.34M$12.75M-$23.32K$1.36M$10.15K$892.83K$372.80K
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$7.01M-$2.97M-$4.76M-$6.60M-$6.03M-$4.78M$1.37M-$652.97K-$181.27K-$323.90K
    Capital expenditures$43.41K$183.70K$444.73K$12.73K$454.65K$88.93K$64.84K$19.40K$0$15.70K
    Free cash flow-$7.06M-$3.16M-$5.20M-$6.62M-$6.48M-$4.86M$1.31M-$672.37K-$181.27K-$339.60K
    Investing cash flow-$2.75M$363.89K-$2.49M-$81.22K-$2.15M-$187.25K-$114.71K-$19.40KN/A-$15.70K
    Financing cash flow$11.10M$3.12M$7.39M$1.09M$3.77M$13.82M-$229.47K$858.86K$54.63KN/A
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Operating cash flow-$1.10M-$1.92M$25.21K-$1.78M-$1.72M-$3.55M-$617.38K-$640.81K-$1.46M-$260.56K-$714.88K-$1.25M
    Capital expenditures$190.43K$210.00K$11.82K$8.06K$8.88K$14.65K$78.87K$3$55.13K$49.70K$75.00K$108.22K
    Free cash flow-$1.29M-$2.13M$13.38K-$1.78M-$1.73M-$3.56M-$696.25K-$640.81K-$1.51M-$310.25K-$789.88K-$1.36M
    Last 12 quarters

    Frequently Asked Questions About IVF

    What is INVO Fertility's annual revenue?

    INVO Fertility reported revenue of $6.84M for the fiscal year ended Dec 31, 2025.

    How fast is INVO Fertility's revenue growing?

    Revenue was up 4.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 102.6%.

    Is INVO Fertility profitable?

    No. INVO Fertility reported net income of -$23.32M for the fiscal year ended Dec 31, 2025, with a net margin of -340.9%.

    How much free cash flow does IVF generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$7.01M minus capital expenditures of $43.41K produced free cash flow of -$7.06M.

    How much debt does INVO Fertility have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $744.73K, short-term debt of $1.48M and cash and equivalents of $2.08M.